MedPath

Clinical Testing of Beverly Hills

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:1
Completed:1

Trial Phases

2 Phases

Early Phase 1:3
Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Early Phase 1
3 (60.0%)
Phase 1
2 (40.0%)

Purified Exosome Product (PEP) Injected Into the Hypodermis

Phase 1
Recruiting
Conditions
Safety
Interventions
Drug: PEP (Purified Exosome Product)
First Posted Date
2024-05-24
Last Posted Date
2025-03-21
Lead Sponsor
Clinical Testing of Beverly Hills
Target Recruit Count
9
Registration Number
NCT06429033
Locations
🇺🇸

Clinical Testing of Beverly Hills, Encino, California, United States

Xeomin Treatment of Glabellar Lines Using OLD Versus COLD

Early Phase 1
Conditions
Glabellar Frown Lines
Interventions
First Posted Date
2022-03-31
Last Posted Date
2022-03-31
Lead Sponsor
Clinical Testing of Beverly Hills
Target Recruit Count
40
Registration Number
NCT05305768
Locations
🇺🇸

Clinical Testing of Beverly Hills, Encino, California, United States

🇺🇸

Alexander Rivkin MD, Los Angeles, California, United States

Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD

Early Phase 1
Completed
Conditions
Glabellar Frown Lines
Interventions
First Posted Date
2021-11-22
Last Posted Date
2024-02-06
Lead Sponsor
Clinical Testing of Beverly Hills
Target Recruit Count
30
Registration Number
NCT05129319
Locations
🇺🇸

Clinical Testing of Beverly Hills, Encino, California, United States

Duration of Botox Using OLD Versus COLD for Treatment of Glabellar Lines

Early Phase 1
Conditions
Glabellar Frown Lines
Interventions
First Posted Date
2021-10-19
Last Posted Date
2021-10-27
Lead Sponsor
Clinical Testing of Beverly Hills
Target Recruit Count
40
Registration Number
NCT05083286
Locations
🇺🇸

Clinical Testing of Beverly Hills, Encino, California, United States

🇺🇸

Steve Yoelin MD, Newport Beach, California, United States

Dysport Dose-Ranging Treatment of Platysmal Bands

Phase 1
Active, not recruiting
Conditions
Platysma Bands
Interventions
First Posted Date
2021-05-13
Last Posted Date
2022-10-12
Lead Sponsor
Clinical Testing of Beverly Hills
Target Recruit Count
30
Registration Number
NCT04886167
Locations
🇺🇸

Clinical Testing of Beverly Hills, Encino, California, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath